Clinical Trial Update: ATAC - Arimidex, Tamoxifen Alone or in Combination [Phase 3]

View source ↗

Summary

Phase 3 ATAC trial evaluating Arimidex, Tamoxifen alone or in combination has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED